Pharmaceutical Investing AVITA Medical Announces Institutional Placement of A$16.0 Million to Support U.S. Commercialization of the RECELL Device
Pharmaceutical Investing Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
Avalon GloboCare Teams up with Weill Cornell Medicine to Establish Joint Translational Research Initiative
Capricor Receives FDA Regenerative Medicine Advanced Therapy Designation for Duchenne Muscular Dystrophy Therapy
